ProMIS™ Neurosciences, Inc.

📍 Toronto, Canada🗓 Founded 2015👥 19 employees💰 Last funded Jul 2017
Biotechnology Research🌐 promisneurosciences.com
Website LinkedIn
ProMIS Neurosciences is focused on the treatment of Alzheimer’s disease, amyotrophic lateral sclerosis and multiple system atrophy through the discovery and development of antibodies selective for toxic misfolded proteins driving these diseases.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2015
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in ProMIS™ Neurosciences, Inc.?
ProMIS™ Neurosciences, Inc. has 1 investors on record on gritt.io, including 1 early-stage backers.
When did ProMIS™ Neurosciences, Inc. last raise funding?
The most recent investment in ProMIS™ Neurosciences, Inc. recorded on gritt.io was in July 2017.
When was ProMIS™ Neurosciences, Inc. founded?
ProMIS™ Neurosciences, Inc. was founded in 2015.
What industry is ProMIS™ Neurosciences, Inc. in?
ProMIS™ Neurosciences, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is ProMIS™ Neurosciences, Inc. based?
ProMIS™ Neurosciences, Inc. is headquartered in Toronto, Canada.